Adverse events of anti-IL-5 drugs in patients with eosinophilic asthma: a meta-analysis of randomized controlled trials and real-world evidence-based assessments

被引：0
作者：
Wen Li
Shi-Chao Tang
Lei Jin
机构：
[1] Shanghai Jiao Tong University School of Medicine,Department of Rheumatology and Immunology, Tongren Hospital
[2] Shanghai Jiao Tong University School of Medicine,Department of Rheumatology, Immunology & Allergy, Shanghai General Hospital
[3] Shanghai Jiao Tong University School of Medicine,undefined
来源：
BMC Pulmonary Medicine | / 24卷
关键词：
Mepolizumab; Benralizumab; Reslizumab; Anti-interleukin-5; Adverse events; Eosinophilic asthma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 27 条
  • [21] Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials
    Lan, Shao-Huan
    Lai, Chih-Cheng
    Chang, Shen-Peng
    Hsu, Chun-Chun
    Chen, Cheng-Hsin
    Wang, Ya-Hui
    Huang, Yueh Lan
    Wang, Cheng-Yi
    Lin, You-Shuei
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2022, 55 (01) : 26 - 35
  • [22] Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials
    de Moraes, Francisco Cezar Aquino
    Sano, Vitor Kendi Tsuchiya
    Pereira, Caroline R. M.
    de Laia, Estella Aparecida
    Stecca, Carlos
    Magalhaes, Maria Cristina Figueroa
    Burbano, Rommel Mario Rodriguez
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (09) : 1373 - 1385
  • [23] Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials
    Nabrdalik, Katarzyna
    Skonieczna-Zydecka, Karolina
    Irlik, Krzysztof
    Hendel, Mirela
    Kwiendacz, Hanna
    Loniewski, Igor
    Januszkiewicz, Kornelia
    Gumprecht, Janusz
    Lip, Gregory Y. H.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [24] Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
    Shin, Sooyoung
    Noh, Yoojin
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 833 - 847
  • [25] Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
    Campbell, Laura
    Chen, Chen
    Bhagat, Shweta S.
    Parker, Richard A.
    Oestoer, Andrew J. K.
    RHEUMATOLOGY, 2011, 50 (03) : 552 - 562
  • [26] Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials
    Laukhtina, Ekaterina
    Mori, Keiichiro
    Mostafaei, Hadi
    Merseburger, Axel S.
    Nyirady, Peter
    Moschini, Marco
    Quhal, Fahad
    Pradere, Benjamin
    Motlagh, Reza Sari
    Enikeev, Dmitry
    Shariat, Shahrokh F.
    SEMINARS IN ONCOLOGY, 2021, 48 (03) : 181 - 192
  • [27] Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non-small-cell lung cancer: A network meta-analysis of nine eligible randomized controlled trials involving 5,059 patients
    Liu, Gui-Feng
    Li, Xue-Feng
    Yu, Shao-Nan
    Miao, Ying-Ying
    Zhang, Shu-Hua
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) : 3445 - 3457
123